CONDITIONAL MUTAGENESIS TO STUDY C MYB FUNCTION

条件诱变研究 C MYB 功能

基本信息

  • 批准号:
    6489383
  • 负责人:
  • 金额:
    $ 28.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-01-05 至 2005-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Applicant's Abstract): It is clear that the c-myb protooncogene plays a crucial role during hematopoiesis. In each hematopoietic lineage, c-myb is abundantly expressed at the immature stages of differentiation and is turned off at a relatively late time during the differentiation process. However, virtually nothing is known about what role c-myb plays during hematopoietic maturation, how that role is mediated or what the signaling pathways are that regulate c-myb expression. Mice that are homozygous null at the c-myb locus die at day fifteen during embryogenesis from a severe anemia. This finding graphically demonstrated the significance of c-myb during hematopoiesis but has precluded study of c-myb activity at the later stages of differentiation. The lack of a tractable genetic system that will allow mutation of c-myb during the later stages of hematopoietic maturation has been a major impediment to understanding the role of c-myb during hematopoiesis. During T-cell development in the thymus, c-myb is expressed in CD4+CD8+ double positive thymocytes but is expressed at essentially undetectable levels in CD4+ and CD8+ single positive cells. In the periphery, c-myb is not expressed in resting T-cells, but is expressed in proliferating T-cells in late Gi/early S-phase of the cell cycle. To begin to understand the role played by c-myb during T-cell development we have produced mice that carry a c-myb allele targeted with loxP sites for deletion by the Cre recombinase. By breeding these mice to available mouse strains that direct Cre expression either to the early stages of T-cell development in the thymus or in an inducible fashion, we will define the role played by c-myb during T-cell development and the activation of effector functions. In addition, these mice will be crucial to the field and will allow one to begin to gain insight into c-myb function during hematopoiesis as well as in other systems where c-myb function remains poorly understood. The goals of this proposal are: 1) to determine at what stage c-myb expression is essential for T-cell development and function, 2) to determine the consequences of inappropriate c-myb expression to T-cell development and function and 3) to identify c-myb functional domains required to drive T-cell development in the thymus.
说明(申请人摘要):很明显,c-myb原癌基因 在造血过程中起着至关重要的作用在每个造血谱系中,c-myb 在分化的不成熟阶段大量表达, 在分化过程中相对较晚的时间关闭。然而,在这方面, 几乎没有人知道c-myb在造血过程中起什么作用。 成熟,这种作用是如何介导的,或者信号通路是什么, 调节c-myb表达。在c-myb基因座上纯合无效的小鼠死亡 在胚胎发生的第15天,由于严重贫血。这一发现 图中显示了c-myb在造血过程中的重要性, 排除了在分化后期对c-myb活性的研究。的 缺乏一个易于处理的遗传系统,将允许c-myb突变期间, 造血成熟的后期阶段一直是 了解c-myb在造血过程中的作用。在T细胞发育过程中 在胸腺中,c-myb在CD 4 + CD 8+双阳性胸腺细胞中表达, 在CD 4+和CD 8+单阳性中以基本上不可检测的水平表达 细胞在外周血中,c-myb在静息T细胞中不表达,但在静息T细胞中表达。 在细胞周期的G1晚期/S早期的增殖T细胞中表达。 为了开始了解c-myb在T细胞发育过程中的作用, 已经产生了携带c-myb等位基因的小鼠,该等位基因靶向loxP位点, 通过Cre重组酶进行缺失。通过将这些老鼠繁殖成可用的老鼠 将Cre表达引导至T细胞分化的早期阶段的菌株 在胸腺中或以诱导的方式发育,我们将定义 c-myb在T细胞发育和效应子激活中的作用 功能协调发展的此外,这些小鼠对该领域至关重要,并将允许 人们开始了解c-myb在造血过程中的功能 如在c-myb功能仍然知之甚少的其它系统中一样。的目标 该建议的主要内容是:1)确定c-myb表达在什么阶段 对T细胞发育和功能至关重要,2)确定后果 c-myb表达不当对T细胞发育和功能的影响; 3) 确定在T细胞中驱动T细胞发育所需的c-myb功能结构域, 胸腺

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Timothy P. Bender其他文献

Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene
c-myb 转基因的晚期上调阻碍了小鼠红白血病细胞的分化
  • DOI:
    10.1128/mcb.10.2.705-710.1990
  • 发表时间:
    1990
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Diana McCLINTON;Jeannine Stafford;Leslie;Brents;Timothy P. Bender;W. Michael;'. Kuehl
  • 通讯作者:
    '. Kuehl
Expression of a transfected human c-myconcogene inhibits differentiation of a mouse erythroleukaemia cell line
转染的人 c-myc 癌基因的表达抑制小鼠红白血病细胞系的分化
  • DOI:
    10.1038/322748a0
  • 发表时间:
    1986-08-21
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Ethan Dmitrovsky;W. Michael Kuehl;Gregory F. Hollis;Ilan R. Kirsch;Timothy P. Bender;Shoshana Segal
  • 通讯作者:
    Shoshana Segal
Considerations for the physical vapor deposition of high molar mass organic compounds
  • DOI:
    10.1016/j.vacuum.2014.05.023
  • 发表时间:
    2014-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jeffrey S. Castrucci;Jeremy D. Dang;Brett A. Kamino;Andrew Campbell;David Pitts;Zheng-Hong Lu;Timothy P. Bender
  • 通讯作者:
    Timothy P. Bender
Redox behaviour of boron subphthalocyanine carbon nanotube composites
  • DOI:
    10.1016/j.nxmate.2024.100163
  • 发表时间:
    2024-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Raunaq Bagchi;Erika Remigio;Dian Yu;Nina F. Farac;Averey Kudlow;Jane Howe;Timothy P. Bender;Keryn Lian
  • 通讯作者:
    Keryn Lian

Timothy P. Bender的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Timothy P. Bender', 18)}}的其他基金

Signaling and Transcriptional Control of T Follicular Helper Cells and RBC Alloimmunization
滤泡辅助 T 细胞和红细胞同种免疫的信号传导和转录控制
  • 批准号:
    9753378
  • 财政年份:
    2018
  • 资助金额:
    $ 28.05万
  • 项目类别:
c-Myb in CD4 T cells is crucial for recall antibody responses
CD4 T 细胞中的 c-Myb 对于记忆抗体反应至关重要
  • 批准号:
    8820986
  • 财政年份:
    2014
  • 资助金额:
    $ 28.05万
  • 项目类别:
c-Myb controls survival, proliferation and differentiation during B-lymphopoiesis
c-Myb 控制 B 淋巴细胞生成过程中的存活、增殖和分化
  • 批准号:
    8478146
  • 财政年份:
    2011
  • 资助金额:
    $ 28.05万
  • 项目类别:
c-Myb fusion proteins in Adenoid Cystic Carcinoma
腺样囊性癌中的 c-Myb 融合蛋白
  • 批准号:
    8303226
  • 财政年份:
    2011
  • 资助金额:
    $ 28.05万
  • 项目类别:
c-Myb controls survival, proliferation and differentiation during B-lymphopoiesis
c-Myb 控制 B 淋巴细胞生成过程中的存活、增殖和分化
  • 批准号:
    8665994
  • 财政年份:
    2011
  • 资助金额:
    $ 28.05万
  • 项目类别:
c-Myb controls survival, proliferation and differentiation during B-lymphopoiesis
c-Myb 控制 B 淋巴细胞生成过程中的存活、增殖和分化
  • 批准号:
    8162936
  • 财政年份:
    2011
  • 资助金额:
    $ 28.05万
  • 项目类别:
ImageSteamX
图像SteamX
  • 批准号:
    8052019
  • 财政年份:
    2011
  • 资助金额:
    $ 28.05万
  • 项目类别:
c-Myb controls survival, proliferation and differentiation during B-lymphopoiesis
c-Myb 控制 B 淋巴细胞生成过程中的存活、增殖和分化
  • 批准号:
    8325520
  • 财政年份:
    2011
  • 资助金额:
    $ 28.05万
  • 项目类别:
c-Myb fusion proteins in Adenoid Cystic Carcinoma
腺样囊性癌中的 c-Myb 融合蛋白
  • 批准号:
    8174241
  • 财政年份:
    2011
  • 资助金额:
    $ 28.05万
  • 项目类别:
Becton Dickinson LSR II
贝克顿·迪金森 LSR II
  • 批准号:
    7594950
  • 财政年份:
    2009
  • 资助金额:
    $ 28.05万
  • 项目类别:

相似海外基金

Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 28.05万
  • 项目类别:
    Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    $ 28.05万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 28.05万
  • 项目类别:
    University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    $ 28.05万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 28.05万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 28.05万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574978-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 28.05万
  • 项目类别:
    University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    $ 28.05万
  • 项目类别:
    Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
  • 批准号:
    RGPIN-2015-05491
  • 财政年份:
    2021
  • 资助金额:
    $ 28.05万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2021
  • 资助金额:
    $ 28.05万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了